Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Pre-Reg Required

CSP Icon

Livestreaming Session Icon

On-Demand Session

CIP Accredited

Additional Fee

CPIA Icon

Human Subjects Research

IACUC/Animal Care and Use

Crossover

Institutional Leadership

Deep Dive Series

Networking Series

Workshop Series

Vendor Insight Series

Thought Leader Series

Pillars Icon

Poster Icons

Record Session Icon

Pre-Reg Required

New for 2020

Part I/II

CSP Icon

Livestreaming Session Icon

Prerecorded Session Icon

CIP Accredited

Pillars Icon

Back

674 Views

Favorite

2022 PRIM&R Annual Conference

A Dialogue With the Feds

C11 - An Update From ORI: Misconduct in Clinical, Translational, and Animal Research: Protocol Violations, Research Misconduct, or Both?

Tuesday, December 13, 2022

11:45 AM – 12:45 PM ET

Location: On-Demand

Presenter(s)

YC

Yvette M. Carter, MD

Office of Research Integrity, Department of Health and Human Services
Rockville, Maryland
LaToya A. Lewis, MT(ASCP), MS, CCRP, CCEP

Office of Research Integrity, Office of the Assistant Secretary for Health (OASH), Department of Health and Human Services (HHS), Maryland
AS

Anuj Sharma, Ph.D

This session will provide insight into institutions’ and ORI’s responses to allegations of research misconduct in human research subjects, translational research, and animal research. Attendees will learn about the institutions’ and ORI’s requirements in response to allegations of research misconduct in accordance with the federal regulations, and what constitutes research misconduct versus unacceptable research practices.

Learning Objectives:

Provide insight into the institutions’ and ORI’s implementation of the US Public Health Service regulations at 42 CFR Part 93, to address allegations of research misconduct
Discuss institutions’ and ORI’s work to ensure institutional compliance with the federal regulations
Share strategies and case studies to address procedural challenges at the institutional level, when investigating allegations of research misconduct in human subjects and unacceptable research practices with animals